Neurocrine Biosciences (NBIX) Q3 Earnings Miss Estimates

Neurocrine Biosciences (NBIX) came out with quarterly earnings of $1.24 per share, missing the Zacks Consensus Estimate of$ 1.47 per share. This compares to earnings of $0.82 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -15.65%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of$ 1.15 per share when it actually produced earnings of $0.63, delivering a surprise of -45.22%. Over the las ...